190 related articles for article (PubMed ID: 19280923)
1. [Recent investigations on the basis of pathogenesis of SLE and new therapeutic approaches].
Watanabe N; Takabayashi K
Nihon Rinsho; 2009 Mar; 67(3):500-5. PubMed ID: 19280923
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus.
D'Cruz DP; Khamashta MA; Hughes GR
Lancet; 2007 Feb; 369(9561):587-96. PubMed ID: 17307106
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
4. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
5. [Allergo-immunology. Clinical immunology].
Chizzolini C
Rev Med Suisse; 2012 Jan; 8(323):11-3. PubMed ID: 22303732
[TBL] [Abstract][Full Text] [Related]
6. [Lupus-nephritis--diagnosis and treatment].
Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
[TBL] [Abstract][Full Text] [Related]
7. The biology behind the new therapies for SLE.
Ermann J; Bermas BL
Int J Clin Pract; 2007 Dec; 61(12):2113-9. PubMed ID: 17997810
[TBL] [Abstract][Full Text] [Related]
8. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
9. Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.
Laskari K; Zintzaras E; Tzioufas AG
Clin Exp Rheumatol; 2010; 28(1):83-6. PubMed ID: 20346244
[TBL] [Abstract][Full Text] [Related]
10. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
Petri M; Jones RJ; Brodsky RA
Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
[TBL] [Abstract][Full Text] [Related]
11. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
12. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Dittrich K; Ross S; Benz K; Amann K; Dötsch J
Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
[TBL] [Abstract][Full Text] [Related]
13. [New treatments for systemic diseases].
Bader-Meunier B; Willems M
Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
[No Abstract] [Full Text] [Related]
14. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
[TBL] [Abstract][Full Text] [Related]
15. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
16. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
[TBL] [Abstract][Full Text] [Related]
17. Update on the management of lupus nephritis: let the treatment fit the patient.
Bertsias G; Boumpas DT
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
[TBL] [Abstract][Full Text] [Related]
18. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
[TBL] [Abstract][Full Text] [Related]
19. [Progress and perspectives in the treatment of systemic lupus erythematosus].
Robak E; Sysa-Jedrzejowska A; Wozniacka A
Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
[TBL] [Abstract][Full Text] [Related]
20. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis.
Marks SD; Tullus K
Acta Paediatr; 2010 Jul; 99(7):967-74. PubMed ID: 20222881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
